News

PMCPA News

Press releases appear below, filter by date.

Making a complaint form outage/issue

Making a complaint form outage/issue

Press release: 12 January 2023
PMCPA launches new social media guidance for pharmaceutical companies

PMCPA launches new social media guidance for pharmaceutical companies 

Press release: 26 January 2023
PMCPA Social Media Guidance 2023 - Recordings and a copy of the slides are now available

PMCPA Social Media Guidance 2023 - Recordings of the webinar and a copy of the slides

Press release: 27 February 2023
New PMCPA Managers - Helen Darracott and Ciara O’Brien

New PMCPA Managers - Helen Darracott and Ciara O’Brien

Press release: 10 March 2023
Vacancies for independent members of the Code of Practice Appeal Board

Vacancies for independent members of the Code of Practice Appeal Board

Press release: 19 April 2023
Changes to PMCPA Case Reports

Changes to PMCPA Case Reports

Press release: 21 April 2023
Q&As from the social media webinar ran by the PMCPA earlier this year are now published

Q&As from the social media webinar ran by the PMCPA earlier this year are now published

Press release: 01 June 2023
Leo Pharma, AstraZeneca and Daiichi Sankyo have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Leo Pharma, AstraZeneca and Daiichi Sankyo have been named in advertisements for bringing discredit upon, and reducing confidence in, the pharmaceutical industry.

Press release: 16 June 2023
Vacancy for the position of Manager, PMCPA (12 Month FTC)

Vacancy for the position of Manager, PMCPA (12 Month FTC)

Press release: 21 June 2023
PMCPA Annual Report

PMCPA Annual Report

Press release: 01 August 2023
Vacancies for independent members of the Code of Practice Appeal Board

Vacancies for independent members of the Code of Practice Appeal Board

Press release: 09 August 2023
Novartis, Roche, Croma Pharma, Daiichi Sankyo, AstraZeneca and AbbVie named in advertisements for breaches of the ABPI Code

Novartis, Roche, Croma Pharma, Daiichi Sankyo, AstraZeneca and AbbVie named in advertisements for breaches of the ABPI Code

Press release: 18 October 2023
About 14 result(s)